NRX Pharmaceuticals financial statements

NRX 파머슈티컬NASDAQ:NRXP · Nasdaq · Healthcare · sector #13
$2.87-1.20%
2026-10-05 close

NRX Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$21M.

Reported results

NRX Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q